Trade Hoth Therapeutics - HOTH CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0156 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.0772 |
| Open | 1.0772 |
| 1-Year Change | -19.85% |
| Day's Range | 1.0572 - 1.0872 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 1.0572 | -0.0100 | -0.94% | 1.0672 | 1.0872 | 1.0472 |
| Feb 20, 2025 | 1.0772 | 0.0000 | 0.00% | 1.0772 | 1.0972 | 1.0472 |
| Feb 19, 2025 | 1.0772 | -0.0500 | -4.44% | 1.1272 | 1.1372 | 1.0072 |
| Feb 18, 2025 | 1.1172 | 0.0200 | 1.82% | 1.0972 | 1.1372 | 1.0972 |
| Feb 14, 2025 | 1.1372 | 0.0500 | 4.60% | 1.0872 | 1.1472 | 1.0672 |
| Feb 13, 2025 | 1.0672 | 0.0200 | 1.91% | 1.0472 | 1.0772 | 1.0072 |
| Feb 12, 2025 | 1.0672 | 0.0700 | 7.02% | 0.9972 | 1.0872 | 0.9972 |
| Feb 11, 2025 | 1.0172 | -0.0200 | -1.93% | 1.0372 | 1.0572 | 0.9871 |
| Feb 10, 2025 | 1.0672 | -0.0600 | -5.32% | 1.1272 | 1.1372 | 1.0272 |
| Feb 7, 2025 | 1.1572 | -0.0500 | -4.14% | 1.2072 | 1.2072 | 1.1472 |
| Feb 6, 2025 | 1.1972 | -0.0400 | -3.23% | 1.2372 | 1.2472 | 1.1972 |
| Feb 5, 2025 | 1.2272 | 0.0000 | 0.00% | 1.2272 | 1.2372 | 1.1972 |
| Feb 4, 2025 | 1.2172 | 0.0100 | 0.83% | 1.2072 | 1.2472 | 1.1972 |
| Feb 3, 2025 | 1.2072 | 0.0200 | 1.68% | 1.1872 | 1.2272 | 1.1472 |
| Jan 31, 2025 | 1.2472 | -0.0400 | -3.11% | 1.2872 | 1.3372 | 1.2172 |
| Jan 30, 2025 | 1.2872 | 0.0600 | 4.89% | 1.2272 | 1.2972 | 1.1972 |
| Jan 29, 2025 | 1.2172 | -0.0200 | -1.62% | 1.2372 | 1.2372 | 1.1972 |
| Jan 28, 2025 | 1.2872 | 0.0800 | 6.63% | 1.2072 | 1.3072 | 1.2072 |
| Jan 27, 2025 | 1.2072 | -0.0700 | -5.48% | 1.2772 | 1.2872 | 1.1972 |
| Jan 24, 2025 | 1.3372 | -0.2100 | -13.57% | 1.5472 | 1.6972 | 1.2672 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Hoth Therapeutics Company profile
About Hoth Therapeutics Inc
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a therapy for dermatological disorders including atopic dermatitis (eczema), chronic wounds, psoriasis, asthma and acne. The Company is also focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer, a treatment for asthma and allergies using inhalational administration, a topical treatment for patients with lupus, a treatment for mast-cell derived cancers and anaphylaxis, and a treatment for lung diseases resulting from bacterial infections. The Company's product pipelines include HT-001, HT-003, HT-004 and others. HT-001 is used to treat patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor (EGFR) inhibitor therapy. It is also developing a COVID-19 treatment as well as a diagnostic device for the detection of viruses via a mobile device.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Hoth Therapeutics Inc revenues was not reported. Net loss increased 68% to $10.8M. Higher net loss reflects Research and development increase from $2.1M to $5.4M (expense), Compensation and related expenses (inclu increase from $1.2M to $2.5M (expense), Other general and administrative expense increase of 68% to $606K (expense).
| Industry: | Pharmaceuticals (NEC) |
1 Rockefeller Plz Ste 1039
10020-2003
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com